Matt Groll

Biography

 Matt Groll brings fifteen years of experience in biotechnology research, development, commercialization and start-up management. He is the co-founder and CEO/President of Quansys Biosciences. He oversees the day to day operations of this 12 year old biotech company, including Sales and Marketing, R&D, Production and Administration activities. Prior to his employment at Quansys, he was the R&D Project Manager at the Spendlove Medical Research Institute where he led the development of the Q-Plex Technology. The technology was then licensed to Quansys Biosciences and he was handpicked to function as the General Manager and in 2016 to serve as CEO. He holds a BS degree in Biology and a MS degree in Biological Engineering from Utah State University as well as an MBA from the University of Utah. With numerous publications in multiplexing technologies and with over 15 years experience in start up business management and assay development, Matt continues to look for and develop innovative new approaches to maximize value for this and other testing applications.

Research Interest

 biotechnology research, development, commercialization and start-up management